Document is current
Any future updates will be listed below
-
Authors
Hendrianus, Hendrianus
Ahn, Jong-Hwa
Kang, Min-Gyu
Kim, Kye-Hwan
Koh, Jin-Sin
Kim, Sang-Wook
Hwang, Jin-Yong
Tantry, Udaya S.
Gurbel, Paul A.
Park, Jeong-Rang
Jeong, Young-Hoon https://orcid.org/0009-0009-9479-2822
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02250963 at ClinicalTrials.govDocuments that mention this clinical trial
Association of thrombogenicity indices with perioperative cardiovascular events after non-cardiac surgery: a prespecified analysis of the PANDA study
https://doi.org/10.1007/s11239-026-03299-z
-
Funding
Funding for this research was provided by:
Chung-Ang University Gwangmyeong Hospital
- License Information
-
More Information
Article History
Received: 16 February 2026
Accepted: 19 April 2026
First Online: 18 May 2026
Declarations
:
: Dr Gurbel has received grants and personal fees from Dr. Gurbel has received consulting fees and/or honoraria from Baron and Budd, Cleveland Clinic foundation, Medtronic, Wolters Kluwer Pharma; grants from Abcentra LLC, Accriva Diagnostics, Alnylam Pharmaceuticals, Covance, Eli Lilly, Haemonetics, Hikari Dx, Idorisa, Instrumentation labs, Medtronic, Novartis, Prolocor, Recor Medical; and has patents ‘Detection of Restenosis Risk in Patients Issued’ and ‘Assessment of Cardiac Health and Thrombotic Risk in a Patient’. Dr Jeong has received honoraria for lectures from Daiichi Sankyo, Sanofi-Aventis, Han-mi Pharmaceuticals, and Daewoong Pharmaceuticals and research grants or support from Samjin Pharmaceuticals, Hanmi Pharmaceuticals, Yuhan Pharmaceuticals, Biotronik Korea, and U and I Corporation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
